Greece
Tuberculosis profile
Population  2012 11 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.076 (0.073–0.08) 0.69 (0.65–0.72)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.01 (0–0.01)
Prevalence  (includes HIV+TB) 0.71 (0.31–1.3) 6.3 (2.8–11)
Incidence  (includes HIV+TB) 0.5 (0.44–0.57) 4.5 (3.9–5.1)
Incidence (HIV+TB only) <0.01 (<0.01–<0.01) 0.04 (0.03–0.04)
Case detection, all forms (%) 100 (91–120)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 229 (51) Relapse 0 (0)
Smear-negative 85 (19) Treatment after failure 0 (0)
Smear-unknown / not done 74 (16) Treatment after default 1 (3)
Extrapulmonary 57 (13) Other 38 (97)
Other 5 (1)      
Total new 450   Total retreatment 39  
           
Other (history unknown) 68        
Total new and relapse 450   Total cases notified 557  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 2.9 2.4 1.5
Age < 15 5 28 2
Laboratories 2012
Is second-line drug susceptibility testing available? Yes, in and outside
country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive     Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary    
Retreatment    
TB/HIV 2012 Number (%)
TB patients with known HIV status    
HIV-positive TB patients    
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 0.87 (0.02–4.7) 6.7 (0.17–32)
MDR-TB cases among notified pulmonary
TB cases
3 (0–19) 3 (0–12)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 0 (0%) 0 (0%) 0
Laboratory-confirmed MDR-TB cases 0 0 0
Patients started on MDR-TB treatment      
Financing TB control 2013
National TB programme budget (US$ millions)  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-24 Data: www.who.int/tb/data